A partnership with the proteasome; the destructive nature of GSK3.

Authors:
Robertson H; Hayes JD; Sutherland C.

Journal:
Biochem Pharmacol

Publication Year: 2017

DOI:
10.1016/j.bcp.2017.10.016

PMCID:
PMC5954166

PMID:
29102676

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Biochem Pharmacol

Abbreviation: Biochem Pharmacol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Biochemistry

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Adipocyte-derived kynurenine stimulates malignant transformation of mammary epithelial cells throug…
Diedrich JD; Gonzalez-Pons R; Medeiros HCD and 5 more (2023) - Transparency Score: 3/6
A high-density 3-dimensional culture model of human glioblastoma for rapid screening of therapeutic…
Brown JMC; Zaben M; Ormonde C and 5 more (2023) - Transparency Score: 3/6
An in vitro assay to investigate venom neurotoxin activity on muscle-type nicotinic acetylcholine r…
Patel RN; Clare RH; Ledsgaard L and 5 more (2023) - Transparency Score: 3/6
Lung cancer associated with combustion particles and fine particulate matter (PM<sub>2.5</sub>) - T…
Holme JA; Vondráček J; Machala M and 5 more (2023) - Transparency Score: 3/6
Counter-regulatory renin-angiotensin system in hypertension: Review and update in the era of COVID-…
Chen H; Peng J; Wang T and 4 more (2022) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
1/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:

"The authors work on GSK3 has been supported by MRC award MR/N009851/1 (JH and CS), a BBSRC studentship (to HR) and the British Heart Foundation award number PG/12/3/29344 (to CS)."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025